Catalyst Wire Dossier Catalyst Wire Dossier

Amlodipine/Valsartan (combination therapy)

amlodipine; valsartan · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Amlodipine/Valsartan (combination therapy), covering 2011-10-19 to 2011-10-19. Get the full timeline:

Most recent: Clinical Trial Update: To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone [Phase 4]

See pricing